Table 1. Baseline characteristics in long-term dialysis patients.
| Parameter | Study group Mean ± SD n = 55 |
Males Mean ± SD n = 28 |
Females Mean ± SD n = 27 |
|---|---|---|---|
| Age [years] | 68.6±16.2 | 73.1±12.8 | 63.8±18.1 |
| Time on HD [months] | 49.44±34.3 | 53.48±37.15 | 46.12±32.53 |
| BMI [kg/m2] | 27.14±6.77 | 27.79±8.18 | 26.53±5.22 |
| Kt/V | 1.69±0.28 | 1.52±0.2* | 1.84±0.27 |
| Hemoglobin [g/dL] | 10.4±1.3 | 10.6±1.0 | 10.26±1.53 |
| EPO dose [U/kg] | 66.9±37.3 | 62.4±38.6 | 71.0±36.5 |
| CRP [μg/mL] | 4.97±3.95 | 7.51±4.64* | 3.4±2.56 |
| IL-6 [pg/mL] | 86.99±29.91 | 79.19±31.9 | 92.19±28.64 |
| Total Calcium [mmol/L] | 2.21±0.19 | 2.2±0.13 | 2.21±0.23 |
| Phosphorus [mg/dL] | 1.61±0.55 | 1.59±0.48 | 1.63±0.62 |
| PTH [pg/mL] | 632.9±510.3 | 478.9±208.5 | 738.8±627.0 |
| Urea [mg/dL] Before HD | 107.84±28.51 | 112.44±28.77 | 103.59±28.14 |
| Urea [mg/dL] After HD | 26.28±10.37 | 30.56±10.42* | 22.33±8.78 |
| Comorbidity score | 6.96±3.19 | 7.57±3.22 | 6.47±3.18 |
| Renalase [ng/mL] | 81.91±19.0 | 83.46±16.26 | 80.49±21.45 |
| miRNA-146a | 0.86±0.19 | 0.88±0.18 | 0.84±0.2 |
| Diastolic blood pressure [mm/Hg] | 70.57±10.29 | 70.4±9.83 | 70.74±10.88 |
| Systolic blood pressure [mm/Hg] | 131.01±21.6 | 132.2±19.08 | 129.92±24.12 |
| MAP [mmHg] | 90.67±12.22 | 90.92±11.2 | 90.44±13.3 |
Data are presented as mean ± Standard Deviation (SD)
* P < 0.05—Compared males vs. females
BMI, Body Mass Index; Kt/V, number used to quantify hemodialysis treatment adequacy; EPO, erythropoietin; CRP, C-Reactive Protein; PTH, parathyroid hormone; HD, hemodialysis; MAP, mean arterial pressure.